Digital Healthcare / Medical Devices - Ambulatory Cardiac Monitoring
Strategic Profile
This company is dominating the ambulatory cardiac monitoring market with its Zio platform, which combines a simple wearable patch with powerful, AI-driven cloud analytics, effectively capturing over 30% of the core market share and serving more than 2 million patients annually. The company is projected to be free cash flow positive for the full year 2025, a major milestone that proves the business model's underlying financial health and scalability.
Cyborg Score Rationale
iRhythm demonstrates strong market dominance with 30%+ market share, achieving FCF profitability in 2025 after years of investment. The company has a defensible technology moat through proprietary algorithms and serves a large TAM with high recurring revenue from healthcare systems and payers.
Top Insights
Market leader in ambulatory cardiac monitoring with >30% core market share and 2M+ patients annually
Achieved inflection to FCF profitability in 2025 after years of heavy R&D investment
Service-based model with recurring revenue from healthcare systems and payers reduces market risk
Partnership with Verily Life Sciences for next-generation atrial fibrillation technology signals AI/ML expansion capabilities
Named Competitors
BioTelemetry — Remote cardiac monitoring and arrhythmia detection
AtriCure — Atrial fibrillation surgical and device solutions
Philips — Healthcare monitoring and diagnostic systems